Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 2/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.47 |
| ▸ | TACR2 | P21452 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2863755 | 0.98 | PLK1 (0.52) | PLK1HPGDPOLBNPC1RAB9A | |
| SCHEMBL27496644 | 0.93 | ESR1 (0.55) | CA2ALDH1A1LMNAHSD17B10ESR1 | |
| SCHEMBL30468687 | 0.91 | ESR1 (0.59) | ALDH1A1LMNAHSD17B10ESR1ADRA2A | |
| SCHEMBL4083403 | 0.91 | ESR1 (0.59) | ALDH1A1LMNAHSD17B10ESR1ADRA2A | |
| SCHEMBL19513921 | 0.91 | ESR1 (0.59) | ALDH1A1LMNAHSD17B10ESR1ADRA2A | |
| SCHEMBL8963454 | 0.91 | ESR1 (0.59) | ALDH1A1LMNAHSD17B10ESR1ADRA2A | |
| SCHEMBL4089466 | 0.91 | ESR1 (0.59) | ALDH1A1LMNAHSD17B10ESR1ADRA2A | |
| SCHEMBL8963483 | 0.91 | ESR1 (0.59) | ALDH1A1LMNAHSD17B10ESR1ADRA2A | |
| SCHEMBL15766189 | 0.91 | ESR1 (0.59) | ALDH1A1LMNAHSD17B10ESR1ADRA2A | |
| SCHEMBL4093509 | 0.91 | ESR1 (0.59) | ALDH1A1LMNAHSD17B10ESR1ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250377301-A1 | STABILISED FLUOROPHORES, COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | FREISTAAT BAYERN LUDWIG MAXIMILIANS UNIV MUENCHEN (DE) | 2025-12-11 | — | — | US | disclosed |
| US-11414436-B2 | Non-coordinating anion type activators containing cation having large alkyl groups | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-08-16 | — | — | US | disclosed |
| EP-2968330-B1 | COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS | SCRIPPS RESEARCH INST (US) | 2021-09-29 | — | — | EP | disclosed |
| US-20190330139-A1 | Non-Coordinating Anion Type Activators Containing Cation Having Large Alkyl Groups | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-10-31 | — | — | US | disclosed |
| CN-109678852-A | 6- oxo hexahydropyrimidine derivative, preparation method and pharmacy application | 南京中医药大学 | 2019-04-26 | — | — | CN | disclosed |
| WO-2018138591-A1 | CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF | PFIZER INC. (US) | 2018-08-02 | — | — | WO | disclosed |
| WO-2017192811-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-11-09 | — | — | WO | disclosed |
| EP-2509600-B1 | THERAPEUTICALLY ACTIVE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER CHARACTERIZED AS HAVING AN IDH MUTATION | AGIOS PHARMACEUTICALS INC (US) | 2017-08-02 | — | — | EP | disclosed |
| CN-103890056-B | Carbon fiber-reinforced thermoplastic resin composition, molding material, prepreg, and methods for producing same | TORAY INDUSTRIES | 2015-07-22 | — | — | CN | disclosed |
| CN-102791750-B | Ethylene-alpha-olefin copolymer and molded article | SUMITOMO CHEMICAL CO.,LTD. (JP) | 2014-10-29 | — | — | CN | disclosed |
| EP-0849292-B1 | Olefin polymerisation catalysts and processes for producing olefin polymers | TOSOH CORP (JP) | 2002-08-21 | — | — | EP | disclosed |
| US-6372681-B1 | METALLOCENE OF TRANSITION METAL AND; METAL OXIDE, SULFIDE, PHOSPHIDE, CARBIDE, NITRIDE, AND/OR SELENIDE; ORGANOALKALINE EARTH OR ZINC COMPOUND; AND ORGANOALUMINUM COMPOUND | TOSOH CORPORATION (JP) | 2002-04-16 | — | — | US | disclosed |
| CN-1306011-A | Polyaddition catalyst component, polyaddition catalyst and method for preparing addition polymer | SUMITOMO CHEMICAL CO (JP) | 2001-08-01 | — | — | CN | disclosed |
| EP-1044997-A2 | Aromatic aldehyde resins and their use as demulsifier | Clariant GmbH (DE) | 2000-10-18 | — | — | EP | disclosed |
| US-6110858-A | AN OLEFIN POLYMERIZATION CATALYST CONSISTS OF A TRANSITION METAL COMPOUND, A MODIFIED CLAY COMPOUND CONTAINING CLAY MINERAL AND AN AMINE COMPOUND AND AN ORGANOALUMINUM COMPOUND | TOSOH CORPORATION (JP) | 2000-08-29 | — | — | US | disclosed |
| EP-0942006-A2 | Catalyst for olefin polymer production and process for olefin polymer production employing the catalyst | TOSOH CORPORATION (JP) | 1999-09-15 | — | — | EP | disclosed |
| EP-0849292-A1 | Olefin polymerisation catalysts and processes for producing olefin polymers | TOSOH CORPORATION (JP) | 1998-06-24 | — | — | EP | disclosed |
| US-4436641-A | ANTHRAQUINONE DYES | RACON INCORPORATED (US) | 1984-03-13 | — | — | US | disclosed |
| US-4369120-A | ANTHRAQUINONE DYES | RACON INCORPORATED (US) | 1983-01-18 | — | — | US | disclosed |
| US-3981717-A | ANILINO COMPOUNDS | AMERICAN CYANAMID COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250377301-A1 | STABILISED FLUOROPHORES, COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | CRY1, MKI67, IK | PLK1 3320/4885HPGD 1757/4885POLB 2812/4885 |
| US-11414436-B2 | Non-coordinating anion type activators containing cation having large alkyl groups | KCNK10, KCNK4, HCN4 | PLK1 1885/4885HPGD 2481/4885POLB 3297/4885 |
| US-20190330139-A1 | Non-Coordinating Anion Type Activators Containing Cation Having Large Alkyl Groups | KCNK10, KCNK4, HCN4 | PLK1 1872/4885HPGD 2459/4885POLB 3299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.